NCT01407848

Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: University of Cologne · Academic / Other
• Sex: All
• Age: 6 Hours
• Healthy volunteers: Not accepted

Summary

In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with Transient Tachypnoea.

Detailed description

In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with transient Tachypnoea. Patients received nebulised Furosemide iv solution 1 mg/kg or nebulised 0,9% saline (4x/d) under blind conditions in random order so long as need a CPAP-treatment but max. 3 days. 20 Patient will be treating. The benefit will be measured as reduction of dyspnea, respiratory rate, oxygen demand and time on CPAP.

Conditions

• Transient Tachypnoea of the Newborn

Interventions

Type	Name	Description
DRUG	Furosemide	Patients received nebulised Furosemide iv solution 1 mg/kg (4x/d) for max.3 consecutive days.
DRUG	Saline 0,9%	nebulised 0,9% saline 4x/d for max.3 days

Timeline

• Start date: 2012-01-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2011-08-02
• Last updated: 2015-09-23

Locations

1 site across 1 country: Germany